MedTrace Logo

Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology

NCT06753045 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2026-03-05

No results posted yet for this study

Summary

This is a phase 0, non-interventional, longitudinal, electronic data capture (EDC) study to facilitate the HEARTBEAT Study project has set out to explore the potential use of smartwatches in collecting and analyzing biometric data to improve the detection, identification, and understanding of cardiovascular diseases and related conditions by SAMSUNG and Tulane. The study will include up to ten thousand adult subjects tasked with wearing a smartwatch to collect digital biomarker data over a 1 year period. Concurrent to smartwatch data collection, subjects will be instructed to complete questionnaires via the Huma Decentralized Clinical Trials (HUMADCT) platform. There are no investigational drugs or interventions administered as part of this study.

Conditions

  • Heart Diseases

Interventions

OTHER

Smartwatch

Sensors on the smartwatch will measure vitals such as heart rate, blood pressure, oxygen saturation, body composition, and electrocardio gram (ECG)

Sponsors & Collaborators

  • Samsung Electronics

    collaborator INDUSTRY

  • Tulane University

    lead OTHER

Principal Investigators

  • Nassir Marrouche, MD · Tulane University

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-08
Primary Completion
2027-10-31
Completion
2027-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06753045 on ClinicalTrials.gov